|
Pharmacokinetics of Isavuconazole in Liver Impairment due to Hepatitis (click for details) |
|
|
|
Zygomycosis in Stem Cell Transplant (SCT) Recipients and Patients with Hematologic Malignancy (HM) (click for details) |
|
|
|
Intrapulmonary Pharmacokinetics of Micafungin in Lung Transplant Patients (click for details) |
|
|
|
In Vivo Efficacy of Orally Dosed FG3622, in Murine Models of Disseminated Aspergillosis (click for details) |
|
|
|
Antifungal Pharmacokinetics/Pharmacodynamics: Past, Present and Future (click for details) |
|
|
|
In Vitro Activity of Corifungin, A New Water-Soluble - Bioavailable Polyene, against Aspergillus spp. and Other Medically Important Fungi (click for details) |
|
|
|
Detection of Aspergillus fumigatus in a Rat Model of Invasive Pulmonary Aspergillosis by Real-Time Nucleic Acid Sequence-Based Amplification (NASBA) (click for details) |
|
|
|
New Inhibitors of Ergosterol Biosynthesis in Candida spp.: HMG-CoA Reductase as Molecular Target (click for details) |
|
|
|
In Vitro Activity of Antifungal Combination Therapy against Planktonic and Biofilm Forms of Invasive Isolates of Candida albicans (click for details) |
|
|
|
The Combination of Posaconazole (Posa) and Echinocandins (Ech) as Salvage Therapy of Invasive Aspergillosis (IA) in Hematologic Malignancy Patients (HMP) (click for details) |
|
|
